CIC
IPXL

Cornercap Investment Counsel’s Impax Laboratories, Inc. IPXL Stock Holding History

Cornercap Investment Counsel’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,815
Closed -$485K – 423
2016
Q2 		$485K Buy
+16,815
New +$548K 0.09% 273

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cornercap Investment Counsel's IPXL Position: Q3 2016 in Review

Cornercap Investment Counsel sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 16,815 shares — an estimated $485K sold.

Cornercap Investment Counsel first reported a position in IPXL in Q2 2016 and held it in 1 quarter. The position peaked at $485K in Q2 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Cornercap Investment Counsel reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Cornercap Investment Counsel sold 16,815 Impax Laboratories, Inc. shares in Q3 2016, an estimated $485K.
  • Cornercap Investment Counsel first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 1 quarter.
  • Cornercap Investment Counsel's Impax Laboratories, Inc. position peaked at $485K in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Cornercap Investment Counsel's 13F filing for Q3 2016, filed 14 Nov 2016.